Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03495869 · ClinicalTrials.gov registry record

Feasibility and Validation of a Standard Phenotyping Assessment Battery

A clinical trial, sponsored by Virginia Commonwealth University.

Completed
Registry status
368
Enrollment target

NCT03495869 is a clinical trial that has completed, run by Virginia Commonwealth University. The registered enrollment target is 368 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03495869 has completed, sponsored by Virginia Commonwealth University.

COMPLETED
Registry status
368 participants
Enrollment target

Study Summary

The overall goal of this project is to collect preliminary data on psychosocial measures and behavioral performance comparing individuals with Opioid Use Disorder, Cocaine Use Disorder, dual diagnosis of Opioid and Cocaine Use Disorder, and Healthy Controls in an effort to determine overall feasibility of a phenotypic "fingerprint" for cohorts of individuals with addictions for use during clinical trials.

Trial Details

FieldValue
Enrollment Target 368 participants
Start Date 2018-06-21
Est. Completion 2020-03-16

Sponsor

Virginia Commonwealth University

558 total trials

What the Registry Record Tells You About NCT03495869

The ClinicalTrials.gov registry entry for NCT03495869 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 368 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT03495869 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03495869 about?

NCT03495869 is a clinical study titled "Feasibility and Validation of a Standard Phenotyping Assessment Battery". The overall goal of this project is to collect preliminary data on psychosocial measures and behavioral performance comparing individuals with Opioid Use Disorder, Cocaine Use Disorder, dual diagnosis of Opioid and Cocaine Use Disorder, and Healthy Controls in an effort to determine overall feasibil...

What is the current status of trial NCT03495869?

This trial is currently completed. The enrollment target is 368 participants. The study started on 2018-06-21. Estimated completion is 2020-03-16.

Who is sponsoring clinical trial NCT03495869?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.